Global Thyroid Cancer Drugs Market Status, Trends and COVID-19 Impact Report 2021, Covid 19 Outbreak Impact research report added by Report Ocean, is an in-depth analysis of market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends, and strategies for this market. It traces the market’s historic and forecast market growth by geography. It places the market within the context of the wider Thyroid Cancer Drugs market, and compares it with other markets., market definition, regional market opportunity, sales and revenue by region, manufacturing cost analysis, Industrial Chain, market effect factors analysis, Digital Evidence Management market size forecast, market data & Graphs and Statistics, Tables, Bar &Pie Charts, and many more for business intelligence. Get complete Report (Including Full TOC, 100+ Tables & Figures, and Chart). – In-depth Analysis Pre & Post COVID-19 Market Outbreak Impact Analysis & Situation by Region.
The global thyroid cancer drugs market was valued at US$ 412 million in 2021 and is predicted to reach US$ 1,752 million by 2030; which is expected to experience a compound annual growth rate (CAGR) of 17.6% during the forecast period from 2022- 2030.
Request To Download Sample of This Strategic Report:-https://reportocean.com/industry-verticals/sample-request?report_id=Pol524
Thyroid cancer is termed as a cancer which is developed in the cells of thyroid gland. It doesn’t show initially but grows severe and starts paining with swelling in the neck region. It shows lump in the most of the thyroid cancers can be treated with treatment. Treatments available for thyroid cancer includes radioactive ablation, thyroid stimulating hormone (TSH) suppression therapy, and removal of thyroid gland.
Market Dynamics
Rising cases of thyroid cancer is expected to drive the market. According to National Cancer Institute about 1.2% of men and women are detected with thyroid cancer during their lifespan. According to American Cancer Society, around 52,070 cases of the thyroid have been found in 2019 in US and estimated death recorded is 2170. Additionally, increasing awareness of thyroid cancer is assisting the growth of the market. Government has been raising funds and reimbursement policies are the factors propelling the growth of global thyroid cancer drugs market. According to Cancer Research UK in 2015, there were 3528 new cases of thyroid cancer registered in 2015. However, there are some restraints leading to the growth of the global thyroid cancer drugs market. Incompetence of drugs in providing effective output to thyroid cancer patients is expected as a major challenge for the growth of the global thyroid cancer drugs market. Additionally, patent expiry of patented drugs along with introduction of new generic version of drugs is obstructing growth of global thyroid cancer drugs market.
Global thyroid cancer drugs market is segmented on the basis of treatment, type, end- user, drug type, route of administration and region. Based on type, it is bifurcated into thyroid cancer, hurthle cell cancer, follicular thyroid cancer, anaplastic thyroid cancer and medullary thyroid cancer (MTC). By treatment, it is categorized into medication, radioactive iodine (radioiodine) therapy, hormone therapy, chemotherapy, and surgery. Surgery is further segmented into near-total thyroidectomy, total thyroidectomy and lobectomy. Further based on drug type, thyroid cancer drugs are Ipilimumab, Cabozantinib-S-Malate, Caprelsa (Vandetanib), Doxorubicin Hydrochloride, Cometriq (Cabozantinib-S-Malate), Lenvatinib Mesylate, Nivolumab, Vandetanib and others. By route of administration, it is categorized into injectable, oral and others. On the basis of end- user, it is categorised into oncology clinics, hospitals, research organisations and others. Based on regional prospects, it is classified into North America (Canada, US and Rest of North America), Asia Pacific (China, South Korea, Japan, Rest of Asia Pacific), Europe (Germany, UK, France, Rest of Europe), Rest of the World (Middle East & Africa, Latina America).
Request Full Report :-https://reportocean.com/industry-verticals/sample-request?report_id=Pol524
Major players covered in the global thyroid cancer drug market report are Mylan N.V., Abbott, Bristol-Myers Squibb Company, Teva Pharmaceutical Industries Ltd, AstraZeneca, GlaxoSmithKline plc, Eisai Co., Ltd, Takeda Pharmaceutical Company Ltd, Biovista, Cytori Therapeutics Inc, Bayer AG, Novartis AG, Jerome Stevens Pharmaceuticals Inc, Baxter, Celgene Corporation, Bio-Path Holdings, Inc. and Vascular Biogenics, among others.
Segmentation and Scope of the Global Thyroid Cancer Drugs Market
Global Thyroid Cancer Drugs Market is segmented into treatment, type, end- user, drug type, route of administration and region.
By Type
Thyroid cancer
Hurthle cell cancer
Follicular thyroid cancer
Anaplastic thyroid cancer
Medullary thyroid cancer (MTC)
By Treatment
Medication
Radioactive iodine (radioiodine) therapy
Hormone therapy
Chemotherapy
Surgery
Near-total thyroidectomy
Total thyroidectomy and lobectomy
By Drug Type
Ipilimumab
Cabozantinib-S-Malate
Caprelsa (Vandetanib)
Doxorubicin Hydrochloride
Cometriq (Cabozantinib-S-Malate)
Lenvatinib Mesylate
Nivolumab
Vandetanib
Others
By End Users:
Hospitals
Oncology Clinics
Research Organizations
Others
Get a Sample PDF copy of the report:-https://reportocean.com/industry-verticals/sample-request?report_id=Pol524
By route of administration
Injectable
Oral
Others
By Geography:
North America
US
Canada
Rest of North America
Europe
UK
Germany
Europe
Italy
Rest of Europe
Asia Pacific
Japan
China
South Korea
Rest of Asia Pacific
Rest of World
Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa
Latin America
Mexico
Brazil
Rest of Latin America
Prominent players in the Global Thyroid Cancer Drugs Market among others include
Mylan N.V.
Abbott
Bristol-Myers Squibb Company
Teva Pharmaceutical Industries Ltd
AstraZeneca
GlaxoSmithKline plc
Eisai Co. Ltd
Takeda Pharmaceutical Company Ltd
Biovista
Cytori Therapeutics Inc
Bayer AG
Novartis AG
Jerome Stevens Pharmaceuticals Inc
Baxter
Celgene Corporation
Bio-Path Holdings Inc.
Vascular Biogenics
Key questions answered in theThyroid Cancer Drugs Marketreport are:
How does a global company acquire markets?
What are its core strategies and policies?
What factors will influence the Thyroid Cancer Drugs Market over the forecast period?
What are the factors driving and restraining the market for Thyroid Cancer Drugs Market?
What are the leading competitors in the global market?
Which region is growing at a higher pace in the global market?
Full Report Description, TOC, Table of Figure, Chart, etc:-https://reportocean.com/industry-verticals/sample-request?report_id=Pol524
About Report Ocean:
We are the best market research reports provider in the industry. Report Ocean believes in providing quality reports to clients to meet the top line and bottom line goals which will boost your market share in today’s competitive environment. Report Ocean is a ‘one-stop solution’ for individuals, organizations, and industries that are looking for innovative market research reports.
Get in Touch with Us:
Report Ocean:
Email:sales@reportocean.com
Address: 500 N Michigan Ave, Suite 600, Chicago, Illinois 60611 – UNITED STATES
Tel: +1 888 212 3539 (US – TOLL FREE)
Website:https://www.reportocean.com